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Abstract
Background: A lot of risk factors for mortality have been proposed in hemodialysis patients. However, most of the
findings were derived from the analyses using all of the hemodialysis patients. What we really want to know is the
prognostic factor in stable hemodialysis patients who have good activities of daily living, because it is difficult to
estimate their prognosis by physical appearance.
Methods: This is a 7-year observational study. The study involved registering 631 patients who had undergone
hemodialysis for more than 1 year at enrollment and were still alive more than 1 year after it. Demographic and
clinical data were collected to analyze the relationship with mortality. Moreover, the patients were age-stratified
to investigate age-dependent prognostic factors.
Results: Low serum sodium concentration is an independent risk factor for all-cause and cardiovascular mortality
common to a wide range of ages in stable hemodialysis patients. Causes of hyponatremia included the predialysis blood
glucose level as well as the variables related to nutrition, inflammation, and fluid overload.
Conclusions: Low serum sodium concentration is a significant prognostic factor in stable hemodialysis patients.
Low serum sodium concentration can be a clue to finding current poor glucose control in stable hemodialysis patients.
Predialysis blood glucose level is one of the representative factors correlated with serum sodium concentration.
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Background
To date, a lot of demographic characteristics and clinical data
have been proposed as prognostic factors in hemodialysis
(HD) patients. Diabetic patients have an increased mortality
compared to non-diabetic patients. The variables related to
nutrition and inflammation are also representative risk
factors [1]. The dialysis prescription is important to
control small- and middle-weight-protein uremic toxins,
anemia, and mineral-bone disorder that are associated
with the prognosis of HD patients [2]. However, most of
these findings were derived from the analyses including all
of the HD patients. There are few reports that focus on
stable maintenance HD patients who have good activities
of daily living (ADLs). In reality, clinicians and medical
staff can easily predict the prognosis of patients in poor
condition from their age, appearance, and behavior.
Conversely, it is difficult to estimate the prognosis of
stable HD patients with good ADLs. Consequently,
what we really want to know is a common risk factor in
such stable HD patients.
Low serum sodium concentration is related to mortality
in not only HD patients [3], but also chronic kidney
disease (CKD) [4, 5] and peritoneal dialysis patients [6, 7].
However, the reason why hyponatremia induces an
increased mortality has yet to be fully examined [8].
Intervention to hyponatremia is challenged by individualized
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dialysate sodium prescription [9]. To date, dialysate sodium
prescription has an effect on blood pressure and recovery
time, while the relationship between dialysate sodium
prescription and mortality remains uncertain [10, 11].
There is no solution to preventing a hyponatremia-related
mortality risk without unveiling the hidden contributors
to hyponatremia.
In this study, we investigated the risk factor for all-cause
and cardiovascular mortality in stable HD patients who
had undergone HD for more than 1 year at enrollment
and were still alive more than 1 year after it, because HD
patients have a higher mortality within a year after dialysis
initiation [12] and our purpose is to seek for the prognostic
marker in stable HD patients with good ADLs. Moreover,
we stratified the patients according to their age to clarify
the risk factor for mortality common to a wide range of
ages. In addition, causes of low serum sodium concentra-
tion were evaluated, because low serum sodium was a
common risk factor in our analysis.
Methods
Design and subjects
Seven hundred and forty patients received HD at Kawashima
Hospital in April 2005. Of these, patients (i) who were
visitors and (ii) who had acute illness, significant infec-
tion, or malignancy were initially excluded. Because our
purpose of this study is to seek for the risk factor in
stable maintenance HD patients who have good ADLs,
the patients who had less than 1 year dialysis duration
in April 2005 or who died before the end of March
2006 were also excluded, because the death rate is high
in the first year after the initiation of dialysis treatment
[12] and we wanted to avoid including the patients
who had an unrevealed serious disease related to short
life span.
Finally, 631 patients were included in the first crude
analysis. Every patient received HD three times a week.
In most patients, high-flux membranes with surface area
of 1.4–2.2 m2 were used according to clinical conditions.
The ultrapure dialysate flow was fixed at 500 mL/min.
The blood flow rate was between 220 and 280 mL/min,
and the length of each HD session was between 3.5 and
5 h. Definition of cardiovascular mortality is deaths by
ischemic heart disease, congestive heart failure, cerebro-
vascular disease, and sudden death used in the previous
reports [13, 14]. This observational study was conducted
for 7 years ending March 2012.
Next, we stratified the patients according to their age.
We excluded 34 patients younger than 40 years old,
because no one died within the 7-year observation
period. We also excluded 12 patients older than or equal
to 85 years old, because life expectancy is short. In fact,
among the above mentioned 12 participants, 11 died within
7 years, and one moved 3 years later. The other patients
were dichotomized between 40 and 64 years and 65
and 84 years old and defined as “middle-aged” and
“older” patients, because the median age for prevalent
HD patients was around 65 years old [12]. As a result,
341 patients were included in the middle-aged patient
group, and 244 were involved in the older patient group
in the second, age-stratified analysis.
Demographic and clinical characteristics were collected
in April 2005. Blood samples for biochemical data were
obtained from arteriovenous shunt just before starting the
first HD session of the week. Cumulative mean predialysis
β2-microglobulin was the average value of serum β2-micro-
globulin concentration taken every 6 months. Sodium
concentration and interdialytic weight gain (the percentage
of body weight gain/dry weight) were the average of the
values in the first HD session of the first week in April,
May, and June 2005. Kt/V, normalized protein catabolic
rate (n-PCR) and creatinine generation rate (CGR) were
calculated according to the formula of Shinzato [15, 16].
Serum calcium concentration was adjusted for serum
albumin according to the equation: corrected Ca =mea-
sured Ca + (4.0 - serum albumin in g/dL) [17].
Statistical analysis
All values are expressed as mean ± SD. Spearman’s coeffi-
cients are denoted by rs. Statistical analysis was performed
using SPSS for Windows version 13.0 (SPSS, Inc., Chicago,
IL, USA). The variables related to patients’ survival were
initially examined by univariate Cox proportional hazards
method. Urea nitrogen, creatinine, and hematocrit were
deleted from the analysis because of a strong association
(rs > 0.7) with n-PCR, CGR, and hemoglobin, respectively.
Multivariate Cox proportional hazards analysis were per-
formed to identify the independent risk factor associated
with mortality. In multivariate analysis, age, gender, HD
duration, and diabetic nephropathy as the primary disease
were unconditionally chosen in both full and final model
analysis. The other possible factors associated with mor-
tality that showed P less than 0.15 in univariate analysis
were chosen in full model analysis. Variables that showed
P less than 0.1 in full model analysis were used in final
model analysis. The difference between groups was
analyzed using Student’s t test or Welch’s t test. F test was
used for comparing the factors of the total deviation.
Categorical data were compared by the chi-square test.
Correlation was analyzed by Spearman’s rank correlation.
Single and multiple regression analyses were also per-
formed to explain serum sodium concentration using the
variables above. Predialysis blood glucose level was added
instead of diabetic nephropathy as the primary disease.
The variables that showed P less than 0.05 in single
regression analysis were used as possible factors in
multiple regression analysis. Significance was defined
by P less than 0.05.
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Initially, the analysis was done using sodium concentra-
tion in April 2005. To confirm the results, the analysis was
re-examined using average sodium concentration. The
results were similar so the data obtained using average
sodium concentration are shown in this manuscript.
Results
Low serum sodium concentration is a risk factor for 7-year
all-cause and cardiovascular mortality of patients enrolled
in crude analysis
Six hundred and thirty-one patients undergoing stable
maintenance HD in April 2005 were enrolled in the first
crude analysis. They were aged 24 to 94 years (mean ±
SD, 61.1 ± 12.2 years). There were 395 men and 236
women. The clinical diagnoses of primary renal disease
included chronic glomerulonephritis (n = 286), diabetic
nephropathy (n = 126), nephrosclerosis (n = 22), polycystic
kidney disease (n = 17), toxemia of pregnancy (n = 18),
and others/unknown (n = 162). In the following 7-year
observation period (actual follow-up period: 68.3 ±
23.3 months), 194 patients (30.7%) died. Among the
194 patients who died, 72 patients (11.4%) died from
cardiovascular events. These events consisted of ischemic
heart disease (n = 17), congestive heart failure (n = 23),
cerebrovascular disease (n = 19), and sudden death (n = 13).
Non-cardiovascular deaths suffered from infectious disease
(n = 64), malignancy (n = 13), and the others/unknown
(n = 45) (Table 1). To examine the influential factor for
all-cause mortality, univariate analysis with Cox propor-
tional hazard model was performed. The variables analyzed
were shown in Table 1. Urea nitrogen, creatinine, and
hematocrit were excluded because of a strong correlation
with the other variable as described in the “Methods”
section. Among them, we found that increased age, male
sex, diabetic nephropathy as the primary disease, higher
β2-microglobulin, calcium, lower Kt/V, n-PCR, CGR,
hemoglobin, platelet, albumin, uric acid, mean sodium,
potassium, phosphate, and smaller interdialytic weight
gain were related to mortality which have P less than
0.15 in univariate analysis. Multivariate analysis with
Cox proportional hazard model (full model analysis)
was performed using the variables above extracted in
univariate analysis to identify the independent factor
for mortality. As shown in Table 2, increased age, male
sex, diabetic nephropathy as the primary disease, longer
duration of HD, higher β2-microglobulin, calcium, and
phosphate, lower CGR, hemoglobin, and mean sodium
were the possible factors with P less than 0.1 in full-model
analysis. Finally, we performed multivariate analysis with
Cox proportional hazard model (final model analysis)
again with the possible factors. It revealed that all of the
factors were the independent predictors of mortality in
the final model analysis (P less than 0.05). Concerning
cardiovascular mortality, increased age, male sex, diabetic
nephropathy as the primary disease, and lower n-PCR,
CGR, hemoglobin, albumin, uric acid, mean sodium, and
phosphate were related to mortality which have P less
than 0.15 in univariate analysis. As shown in Table 3, full
and final model analysis revealed that increased age, male
sex, diabetic nephropathy as the primary disease, lower
hemoglobin, and mean sodium were the independent
prognostic factors of mortality. Consequently, hyponatre-
mia was chosen as a risk factor for both all-cause and
cardiovascular mortality in the first crude analysis.
Characteristics of stable middle-aged and older patients
undergoing HD
Next, we wonder whether hyponatremia is a risk factor
common to a wide range of ages or not. Therefore, we
Table 1 Demographic and clinical characteristics of stable
hemodialysis patients enrolled in crude analysis
Number of patients 631
Deaths during follow-up, n (%) 194 (30.7%)
Deaths in cardiovascular disease, n (%) 72 (11.4%)
Age, years 61.1 ± 12.2
Female, n (%) 236 (37.4%)
Diabetic nephropathy, n (%) 126 (20.0%)
Hemodialysis duration, months 110.1 ± 86.2
Body mass index, kg/m2 22.2 ± 3.2
Kt/V 1.51 ± 0.26
Cumu. mean predia. β2-M, mg/L 28.7 ± 5.3
Normalized PCR, g/kg/day 1.01 ± 0.18
Creatinine generation rate, % 100.7 ± 22.2
WBC count, 103/μL 6.09 ± 1.81
Hemoglobin, g/dL 10.6 ± 1.1
Hematocrit, % 32.4 ± 3.6
Platelet count, 103/μL 192.6 ± 56.8
Albumin, g/dL 3.66 ± 0.34
Urea nitrogen, mg/dL 75.3 ± 15.9
Uric acid, mg/dL 7.72 ± 1.18
Creatinine, mg/dL 11.4 ± 2.8
Mean predialysis sodium, mEq/L 139.9 ± 2.8
Potassium, mEq/L 4.86 ± 0.69
Calcium, mg/dL 9.83 ± 0.79
Phosphate, mg/dL 5.16 ± 1.12
Mean interdialytic weight gain, % of DW 4.52 ± 1.31
Actual follow-up period, months 68.3 ± 23.3
Calcium was adjusted for serum albumin according to the equation: corrected
Ca =measured Ca + (4.0 - serum albumin in g/dL)
Urea nitrogen, creatinine, and hematocrit were excluded in crude analysis
because of a strong association with normalized PCR, creatinine generation
rate, and hemoglobin, respectively
Cumu. mean predia. β2-M cumulative mean predialysis β2-microglobulin, PCR
protein catabolic rate. WBC white blood cell, DW dry weight
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divided the stable HD patients into middle-aged and
older patients. As shown in Additional file 1: Table S1,
as expected, older patients had a higher mortality.
Causes of death were shown in Additional file 2: Table S2.
Older patients included a larger percentage of ones
diagnosed with diabetic nephropathy and had shorter
HD duration, lower n-PCR, CGR, hemoglobin, platelet,
albumin, potassium, phosphate, and smaller interdialytic
weight gain, suggesting older patients had lower activity
and nutrient intake than middle-aged patients.
Low serum sodium concentration was selected as a
prognostic factor for 7-year survival of stable middle-aged
patients in age-stratified analysis
In stable middle-aged patients, using the same series of
analysis, increased age, male sex, longer duration of HD,
higher β2-microglobulin, white blood cell (WBC) count,
lower CGR, and mean sodium were the risk factors for
mortality as shown in Additional file 3: Table S3. Moreover,
higher WBC count and lower mean sodium were chosen
as the prognostic factors for cardiovascular mortality as
well as increased age and male sex (Additional file 4:
Table S4). Therefore, hyponatremia was associated with
poor prognosis in stable middle-aged patients.
Low serum sodium concentration was also selected as a
prognostic factor for 7-year survival of stable older-aged
patients in age-stratified analysis
In stable older patients, increased age, male sex, diabetic
nephropathy as the primary disease, higher β2-micro-
globulin, WBC count, lower CGR, hemoglobin, and
mean sodium were the risk factors for mortality as
shown in Additional file 5: Table S5. Moreover, lower
hemoglobin and mean sodium as well as increased age
and diabetic nephropathy as the primary disease were
chosen as the prognostic factors for cardiovascular
Table 2 Significant independent factors associated with all-cause mortality in stable hemodialysis patients
Univariate Multivariate (full model) Multivariate (final model)
Variable HR 95% CI P HR 95% CI P HR 95% CI P
Age (per 1 year) 1.089 1.074–1.104 < 0.001 1.100 1.081–1.119 < 0.001 1.098 1.081–1.116 < 0.001
Gender (vs. female) 1.768 1.289–2.425 < 0.001 1.702 1.172–2.471 0.005 1.759 1.264–2.449 0.001
DN (vs. non-DN) 2.149 1.583–2.915 < 0.001 1.687 1.190–2.392 0.003 1.673 1.184–2.363 0.004
HD duration (per 1 month) 0.999 0.997–1.001 0.269 1.003 1.001–1.005 0.002 1.003 1.001–1.005 0.002
β2M (per 1 mg/L) 1.049 1.023–1.076 < 0.001 1.061 1.033–1.089 < 0.001 1.063 1.037–1.089 < 0.001
CGR (per 1%) 0.979 0.973–0.985 < 0.001 0.980 0.973–0.988 < 0.001 0.980 0.973–0.987 < 0.001
Hemoglobin (per 1 g/dL) 0.803 0.711–0.908 < 0.001 0.866 0.760–0.987 0.032 0.852 0.753–0.964 0.011
Mean sodium (per 1 mEq/L) 0.863 0.822–0.907 < 0.001 0.929 0.885–0.974 0.002 0.919 0.878–0.963 < 0.001
Calcium (per 1 mg/dL) 1.202 0.991–1.457 0.062 1.190 0.983–1.439 0.074 1.236 1.028–1.486 0.024
Phosphate (per 1 mg/dL) 0.771 0.672–0.886 < 0.001 1.213 1.035–1.422 0.017 1.181 1.022–1.365 0.024
In addition to age, gender, hemodialysis duration, and diabetic nephropathy, possible factors that showed P less than 0.15 in univariate analysis such as Kt/V,
β2-microglobulin, protein catabolic rate, creatinine generation rate, hemoglobin, platelet, albumin, uric acid, mean sodium, potassium, calcium, phosphate,
and mean interdialytic weight gain were chosen in full-model analysis
Final model analysis was done with age, gender, hemodialysis duration, diabetic nephropathy, and the variables with P less than 0.1 in full-model analysis such as
β2-microglobulin, creatinine generation rate, hemoglobin, mean sodium, calcium, and phosphate
DN diabetic nephropathy, HD duration hemodialysis duration, β2M cumulative mean predialysis β2-microglobulin, CGR creatinine generation rate, HR hazard ratio,
95% CI 95% confidence interval
Table 3 Significant independent factors associated with cardiovascular mortality in stable hemodialysis patients
Univariate Multivariate (Full model) Multivariate (Final model)
Variable HR 95%CI P HR 95%CI P HR 95%CI P
Age (per 1 year) 1.086 1.061–1.111 < 0.001 1.089 1.060–1.117 < 0.001 1.087 1.061–1.114 < 0.001
Gender (vs. female) 2.148 1.246–3.700 0.006 2.028 1.151–3.572 0.014 1.984 1.131–3.479 0.017
DN (vs. non-DN) 2.546 1.565–4.142 < 0.001 2.050 1.169–3.595 0.012 2.008 1.178–3.423 0.010
HD duration (per 1 month) 0.999 0.996–1.001 0.349 1.001 0.998–1.004 0.425 1.001 0.998–1.004 0.409
Hemoglobin (per 1 g/dL) 0.737 0.608–0.893 0.002 0.752 0.618–0.915 0.004 0.750 0.620–0.906 0.003
Mean sodium (per 1 mEq/L) 0.789 0.731–0.851 < 0.001 0.830 0.768–0.896 < 0.001 0.826 0.767–0.890 < 0.001
In addition to age, gender, hemodialysis duration, and diabetic nephropathy, possible factors that showed P less than 0.15 in univariate analysis such as protein
catabolic rate, creatinine generation rate, hemoglobin, albumin, uric acid, mean sodium, and phosphate were chosen in full model analysis
Final model analysis was done with age, gender, hemodialysis duration, diabetic nephropathy and the variables with P less than 0.1 in full model analysis such as
hemoglobin, and mean sodium
DN diabetic nephropathy, HD duration hemodialysis duration, HR hazard ratio, 95% CI 95% confidence interval
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mortality (Additional file 6: Table S6). Therefore, hypo-
natremia was also associated with poor prognosis in
stable older patients.
Causes of hyponatremia
Causes of hyponatremia were unclear, so we divided
patients by average mean sodium concentration. Then,
as shown in Table 4, the low sodium group consisted of
larger percentages of male sex, patients diagnosed with
diabetic nephropathy, and had higher WBC count, platelet
count, potassium, larger interdialytic weight gain, lower
CGR, albumin, and uric acid. Concerning age-stratified
analysis, in stable middle-aged patients, the low sodium
group consisted of a larger percentage of patients diag-
nosed with diabetic nephropathy and had higher platelet,
calcium, larger interdialytic weight gain, and lower albumin
(Additional file 7: Table S7). In stable older patients, the
low sodium group consisted of larger percentages of male
sex, patients diagnosed with diabetic nephropathy, and had
higher potassium, larger interdialytic weight gain,
lower body mass index, and uric acid (Additional file 8:
Table S8). Thus, low sodium concentration was especially
detected in patients diagnosed with diabetic nephropathy
and/or with larger interdialytic weight gain common to a
wide range of ages.
Non-fasting predialysis blood glucose level was inversely
correlated with serum sodium concentration
The low sodium group consisted of a larger percentage of
patients diagnosed with diabetic nephropathy. Therefore,
we investigated the relationship between non-fasting pre-
dialysis blood glucose level and serum sodium concentra-
tion. Then, we found a weak inverse correlation between
non-fasting predialysis blood glucose level and serum
sodium concentration (rs = − 0.209, 0.204, and 0.237 in
crude analysis, middle-aged patients, and older patients,
respectively) (Fig. 1a–c). Next, we divided the patients with
blood glucose level greater than or equal to 140 mg/dL
from those with blood glucose level less than 140 mg/dL.
We decided the cutoff value according to the diagnostic
criteria of diabetes mellitus [18]. Then, as shown in
Fig. 1d–f, we found a better correlation between blood
glucose level and serum sodium concentration in the
patients with blood glucose level greater than or equal
to 140 mg/dL (rs = − 0.296, 0.392, and 0.157 in crude
analysis, middle-aged patients, and older patients, re-
spectively) than that in the patients with blood glucose
level less than 140 mg/dL (rs = − 0.036, 0.054, and 0.048 in
crude analysis, middle-aged patients, and older patients,
respectively. Data not shown.).
The correlation of interdialytic weight gain and the other
variables with serum sodium concentration
The low sodium group had a larger interdialytic weight
gain common to a wide range of ages. Therefore, we also
investigated the correlation of interdialytic weight gain
with serum sodium concentration. As shown in Fig. 2,
interdialytic weight gain had a weak inverse correlation
with serum sodium concentration especially in older
patients. The other variables shown in Table 1 were not
correlated with serum sodium concentration in all of the
crude analysis, middle-aged patients, and older patients
(rs < 0.2).
Single and multiple regression analysis to explain serum
sodium concentration
Single and multiple regression analyses were performed
to explain serum sodium concentration. However, we
could only find low coefficient of determination (at most
Table 4 Demographic and clinical characteristics of low sodium
or high sodium patients
Low < 139.9 High ≥ 139.9 P
Number of patients 274 357 N/A
Deaths during follow-up, n (%) 108 (39.4%) 86 (24.1%) < 0.001
Deaths in cardiovascular disease,
n (%)
49 (17.9%) 23 (6.4%) < 0.001
Age, years 60.6 ± 12.7 61.5 ± 11.7 0.387
Female, n (%) 89 (32.5%) 147 (41.2%) 0.025
Diabetic nephropathy, n (%) 80 (29.2%) 46 (12.9%) < 0.001
Hemodialysis duration, months 107.4 ± 83.8 112.3 ± 88.0 0.480
Body mass index, kg/m2 21.9 ± 3.3 22.4 ± 3.2 0.114
Kt/V 1.50 ± 0.24 1.51 ± 0.27 0.887
Cumu. mean predia. β2-M, mg/L 29.1 ± 5.4 28.4 ± 5.2 0.113
Normalized PCR, g/kg/day 1.01 ± 0.19 1.01 ± 0.17 0.688
Creatinine generation rate, % 97.7 ± 21.8 103.0 ± 22.2 0.003
WBC count, 103/μL 6.32 ± 1.86 5.92 ± 1.75 0.006
Hemoglobin, g/dL 10.5 ± 1.2 10.6 ± 1.1 0.239
Hematocrit, % 32.2 ± 3.8 32.6 ± 3.4 0.111
Platelet count, 103/μL 199.8 ± 61.7 187.2 ± 52.1 0.006
Albumin, g/dL 3.62 ± 0.36 3.70 ± 0.32 0.003
Urea nitrogen, mg/dL 75.1 ± 17.1 75.4 ± 15.0 0.834
Uric acid, mg/dL 7.59 ± 1.25 7.83 ± 1.11 0.011
Creatinine, mg/dL 11.2 ± 2.7 11.6 ± 2.9 0.064
Mean predialysis sodium, mEq/L 137.3 ± 1.9 141.9 ± 1.3 < 0.001
Potassium, mEq/L 4.93 ± 0.74 4.80 ± 0.66 0.020
Calcium, mg/dL 9.89 ± 0.86 9.78 ± 0.73 0.073
Phosphate, mg/dL 5.11 ± 1.21 5.20 ± 1.05 0.298
Interdialytic weight gain, % of DW 4.81 ± 1.32 4.29 ± 1.26 < 0.001
Calcium was adjusted for serum albumin according to the equation: corrected
Ca =measured Ca + (4.0 - serum albumin in g/dL)
Cumu. mean predia. β2-M cumulative mean predialysis β2-microglobulin, PCR
protein catabolic rate, WBC white blood cell, DW dry weight, N/A
not applicable
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0.165 in older patients) in all of the crude analysis,
middle-aged patients, and older patients (data not shown).
Discussion
In this study, we demonstrated that low serum sodium
concentration is related to poor prognosis in stable HD
patients. The low sodium group had a larger percentage
of patients diagnosed with diabetic nephropathy and
with larger interdialytic weight gain common to a wide
range of ages. Predialysis blood glucose level affected
serum sodium concentration.
The first finding of this study is that hyponatremia is
confirmed as an independent prognostic factor for all-
cause and cardiovascular mortality in stable HD patients
common to a wide range of ages. HD-related guidelines
were established based on the data obtained from all of
the HD patients. What we really need is to find out the
hidden risk factor in stable HD patients with good ADLs
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Fig. 1 Non-fasting predialysis blood glucose level was inversely related to serum sodium concentration. a–c Non-fasting predialysis blood glucose
level was inversely related to serum sodium concentration in crude analysis (a), middle-aged patients (b), and older patients (c). d–f The relationship
between serum sodium concentration and non-fasting predialysis blood glucose level in the patients with blood glucose level greater than or equal
to 140 mg/dL in crude analysis (d), middle-aged patients (e), and older patients (f). Spearman’s coefficients are denoted by rs. The regression equation
was shown in each graph
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Serum sodium concentration is a widely available blood
test item, evaluated on a daily basis. Our study clearly
showed that low serum sodium concentration is important
to forecast the prognosis in stable HD patients, common
to a wide range of ages.
The reason why hyponatremia is associated with poor
prognosis was unknown. Hyponatremia is recognized as
a risk factor in CKD patients [3–8]. However, is hypona-
tremia a direct cause of death in HD patients? Chawla
et al. discussed the role of hyponatremia in mortality in
hospitalized patients [19]. The authors found that more
than two thirds of patients who died after a sodium concen-
tration less than 120 mEq/L had acute severe progressive
illnesses and only 5.6% of the dead patients could plausibly
be related to adverse consequences of hyponatremia. They
concluded that the nature of underlying illness, rather than
the severity of hyponatremia, best explains mortality associ-
ated with hyponatremia. In our study, relatively low sodium
concentration within normal range was related to a higher
mortality. Therefore, we also assume that hyponatremia is
an indirect prognostic factor. We need to find out under-
lying causes of hyponatremia.
More important findings of this study were the analyses
concerning causes of hyponatremia. It is noteworthy that
no correlation was found between serum sodium concen-
tration and the variables shown in Table 1 (rs < 0.2) except
interdialytic weight gain in older patients (Fig. 2). Next,
the low sodium group in our study consisted of more
patients diagnosed with diabetic nephropathy than the
high sodium group. Actually, serum sodium concentration
had a weak inverse correlation with non-fasting predialysis
blood glucose level (Fig. 1). Katz et al. described the-
oretical considerations about hyperglycemia-induced
hyponatremia–calculation of expected serum sodium
depression, demonstrating the serum sodium concen-
tration decreases by 1.6 mEq/l for every 100 mg/dl
increase in glucose concentration due to water shifts from
the intracellular to the extracellular compartment [20].
Penne et al. validated the correction factor in HD patients
and reported that the mean slope for the relation
between serum sodium and glucose concentration −
1.47 ± 0.82 mEq/l per 100 mg/dl increase in glucose
level [21]. In our study, the regression equations in Fig. 1
were consistent with the previous report, and higher
glucose level had better correlation with serum sodium
concentration (Fig. 1d–f ), suggesting serum sodium
concentration was affected by glucose-induced serum
osmolarity. Therefore, when we see the HD patients
with low serum sodium concentration, it can be a
promising clue to diagnosing diabetes newly, because
HbA1c and glycated albumin are influenced by alter-
ations in hemoglobin and albumin metabolism, which
makes it difficult to interpret these values in HD patients
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survival cannot be explained only by diabetic status,
because hyponatremia is an independent risk factor after
adjustment of the existence of diabetic nephropathy as the
primary disease. Coefficient of determination to explain
serum sodium concentration was low in multiple regression
analysis even if we added non-fasting predialysis blood
glucose level as a possible factor. Therefore, hyponatremia
reflects on a mixture of underlying causes. Pérez-García
et al. reported that HD patients with hyponatremia have a
poor prognosis and present malnutrition or fluid overload
[23]. Poulikakos et al. reported that low serum sodium is
associated with protein energy wasting and increased inter-
dialytic weight gain in HD patients [24]. Dekker et al. found
that hyponatremia is associated with malnutrition, inflam-
mation, and fluid overload [25]. Our study supports their
findings because the low sodium group had significantly
lower CGR, higher WBC count, and larger interdialytic
weight gain (Table 4). Interdialytic weight gain was inversely
correlated with serum sodium concentration especially in
older patients (Fig. 2). It might be due to the body water
compartments with human aging. Intracellular water was
reported lower in elderly HD patients than in young HD
patients [26]. Thus, fluid overload may be also related to
poor prognosis in our low serum sodium group.
Consequently, low sodium concentration is a prognostic
marker related to current blood glucose level, as well as
interdialytic weight gain, malnutrition, and inflammation. It
means that the intervention to resolve the causes described
above should be done to correct hyponatremia. Control of
serum sodium concentration by dialysate sodium prescrip-
tion will not have a direct effect on mortality.
The strength of this study is a long observation period.
The limitation is a lack of a representative inflammation
marker such as C-reactive protein. High WBC count
was chosen as a risk factor for all-cause mortality in
age-stratified analysis (Additional file 3: Table S3 and
Additional file 5: Table S5). It suggested that inflamma-
tion is also related to mortality in our cohort. Another
limitation of this study is that the finding of this study
might not be applied to all patients with HD because
the characteristics of enrolled patients were different
from national data concerning age and the rate of the
patients with diabetic nephropathy [3, 12].
Conclusions
In summary, low serum sodium concentration is an easily
detectable and routinely examined prognostic factor in
stable HD patients common to a wide range of ages.
Causes of hyponatremia are complicated. Causes consist of
not only malnutrition, inflammation, and fluid overload but
also the predialysis blood glucose level. Our study
suggested that current diabetic status should be checked
when we see the stable HD patients with low serum
sodium concentration.
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